MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

02 Sep 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 2nd September 2021 titled ‘Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..